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Diabetic patients are threatened by “superbugs”
Acinetobacter baumannii In Saudi Arabia
hospitals
A.A. Al-Sultan
King Faisal University, Alahsa, Saudi Arabia
Background: One of the greatest threat to the recent gen-
eration of antibiotics is the increasing prevalence of bacterial
resistant, speciallyGram-negativebacteria.Acinetobacter baumanni
is one of the most important superbugs becoming increasingly
prevalent in patients with diabetes mellitus in Middle East par-
ticularly in Saudi Arabia. We have shown that diabetic patients are
more susceptible to acquire infection with these type of superbugs
A.baumannii than the rest of thepopulation. Carbapenemresistance
in A.baumannii limits therapeutic options and is largely manifested
by –lactamases and metallo--lactamase that play a signiﬁcant
role inmechanisms of drug-resistance in diabetic patients. The aim
is to investigate the level of threat of these pathogens to diabetics
and the mechanisms of drug-resistance of patients in Saudi Arabia
hospitals.
Methods & Materials: A total of 64 non-repetitive, strains
collected between 2008 to 2012 from different specimens from
diabetic patients from King Faisal Specialist Hospital and Research
Centre, Riyadh. All isolates were identiﬁed by Vitek system. Mul-
tiplex PCR using primers for blaOXA-51 combined with primers for
blaOXA-23, blaOXA-24/40 and blaOXA-58 was employed. PCR was used
for detection of -lactamase and metallo--lactamase genes and
insertion sequences IS elements. Pulsed-ﬁeld gel electrophore-
sis (PFGE) has been performed. MICs was determined by dilution
method.
Results: Sixty-four clinical isolates of A. baumannii having
blaOXA-51-like gene. All isolates were resistant to imipenem and
meropenem (MIC > 16 - 32mg/L) except four were intermediate
(MIC=8mg/L) and Six were susceptible (MIC 0.5 - 2mg/L) to both
of them. All isolates were sensitive to tigecycline and colistin (MIC
0.5 - 2mg/L) except four were resistant (MIC 8-32mg/L) and three
were intermediate to tigecycline only (MIC 4 - 8). The cause of
resistance was from -lactamase of blaOXA-23 and blaOXA-24/40 and
metallo--lactamase blaVIM and blaSPM. Fifty-nine isolates were
possess the insertion sequence ISAba1. PFGE showed Nine clusters
of blaOXA-51-like enzymes.
Conclusion: Carbapenem-resistant Acinetobacter baumannii is
a serious superbugs threaten diabetic patients due to the circu-
lation of -lactamases and metallo--lactamase in Saudi Arabian
hospitals. Furthermore, the emergence of tigecycline plus colistin
resistance is causing a treatment shortfall for these patients.
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Background: Pseudomonas aeruginosa chronically infects cys-
tic ﬁbrosis (CF) patients leading to persistent lung inﬂammation
and, ultimately, death of the patient. In a previous study we have
detected an epidemic P. aeruginosa strain amongst patients attend-
ing the CF reference center in Brussels and three other Belgian CF
reference centers. This strain (next to other P. aeruginosa CF strains)
was characterized by a deletion of the fpvB gene, involved in fer-
ripyoverdine uptake.
Methods & Materials: In order to identify deletions, acquired
during colonization of P. aeruginosa in the CF lung, we decided to
sequence the complete genomeof the epidemic isolate P. aeruginosa
CF PA39. In this study, we analyzed the genome sequence of this
isolate using a combination of bioinformatic tools such as RAST,
IslandViewer, PHAST, and CRISPRFinder.
Results: Interestingly, large deletionsweredetected comprising
the entire type III secretion region (ca. 24 kbp) and the region corre-
sponding to PA2171-PA2226 of the PAOI reference genome (ca. 58
kbp) harboring several amino acid transport, virulence, and resis-
tance genes. Furthermore, we have found ten different genomic
islands, including well-described (LESGI-2, LESGI-4, PADK2 GI-2,
PA7 RGP 69, and PA7 RGP 76) and novel sequences. Interestingly,
using the genome sequence of this epidemic strain, we have iden-
tiﬁed an open reading frame (ORF) encoding a potentially novel
S-type pyocin. This novel pyocin sequence perfectly matched to
the nucleotide sequences of both the receptor binding and translo-
cation domains of pyocin S1. However, the nucleotide sequence
corresponding to the killing domain of this novel pyocin sequence
was completely different compared to that of pyocin S1.Using RT-
PCR, we showed that the expression of the pyocin gene is induced
under iron-limiting conditions. Finally, we have proven the func-
tionality of this pyocin as it was able to inhibit the growth of a
number of P. aeruginosa CF isolates.
Conclusion: In summary, by analyzing the genome sequence
of a highly adapted CF isolate, we gained insight in the adap-
tation of P. aeruginosa to the CF lung at the genomic level and
discovered a novel, hybrid, S-type pyocin, termed pyocin S6.
Moreover, this studyelaborates on the still contentious issue of
highly transmissible clones among CF patients.
http://dx.doi.org/10.1016/j.ijid.2014.03.1145
